Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Genmab

Clinical trials sponsored by Genmab, explained in plain language.

Genmab GMAB NASDAQ

Biotechnology company specializing in antibody therapeutics for cancer and other diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 11 Not yet recruiting 1 Not yet finished but already full! 16 Completed 1 Terminated 12

New cancer drug GEN1056 tested in first human trial

Disease control Completed

This early-stage trial tested a new drug, GEN1056, in 26 people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety and find the best dose. Researchers also looked for signs that the drug might shrink tumors.

Phase: PHASE1 • Sponsor: Genmab • Aim: Disease control

Last updated Jun 27, 2026 07:59 UTC